INS and polycystic ovary syndrome: Mitochondrial mutations in PCOS [16] may lead to impaired oxidative phosphorylation, decreased adenosine triphosphate (ATP) production, and an increased production of reactive oxygen species (ROS), which may contribute to the metabolic and hormonal dysregulation in this condition by disrupting insulin signaling pathways and impairing glucose metabolism [17].